tiprankstipranks
Exelixis (EXEL)
NASDAQ:EXEL

Exelixis (EXEL) Stock Investors

2,730 Followers
Based on 729,985 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold EXEL
On average, investors allocate 3.42% of their portfolios to EXEL
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding EXEL

0.7%
Last 7
Days
6.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding EXEL, out of 729,985 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

EXEL Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.01%
$20.18
Increased
5.72%
$21.80
Increased
0.29%
$22.82
Increased
0.40%
$21.91
Increased
0.65%
$20.72
Opened
0.39%
$21.71
Increased
3.30%
$18.08
Increased
0.47%
$22.24
Based on the activity of 13,711 investors who made their portfolios public
The table shows changes in EXEL in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

EXEL Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.14%
-0.03%
-1.06%
321.34B
Healthcare
Block
4.47%
-1.22%
-8.10%
46.31B
Technology
Trade Desk
4.61%
-0.37%
-4.72%
39.64B
Technology
Micron
5.69%
+0.45%
+8.82%
124.53B
Technology
GE Aerospace
5.47%
+2.12%
+7.19%
177.79B
Industrials
ServiceNow
4.01%
-0.53%
-3.33%
151.89B
Technology
Cisco Systems
4.54%
-0.34%
-4.83%
195.66B
Technology
Mercadolibre
5.28%
-0.98%
-2.99%
70.72B
Consumer Cyclical
Qualcomm
4.80%
-0.75%
-6.25%
180.07B
Technology
Salesforce
4.96%
+0.10%
+0.20%
268.38B
Technology
Based on the activity of 729,985 active portfolios
Open your Smart Portfolio

EXEL Investor Analysis

EXEL investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of EXEL holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
EXEL investors between 35–55

Between 35–55

5.5%
Last 30 days
Holdings Change
50.8%
of EXEL holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
EXEL investors over 55

Over 55

14.3%
Last 30 days
Holdings Change
38.1%
of EXEL holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of EXEL stock investors
See who invests in EXEL according to age group and performance.

FAQ

How many retail Investors hold EXEL?
<0.1% of TipRanks' retail investors hold EXEL in their portfolios.
    What is EXEL Investor Sentiment?
    EXEL’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of EXEL in the last 7 days?
      ▼ 0.7% of TipRanks' retail investors changed their holding of EXEL in the last 7 days.
        What percentage of retail investors changed their holding of EXEL in the last 30 days?
        ▼ 6.2% of TipRanks' retail investors changed their holding of EXEL in the last 30 days.
          What is the average age of retail investors who hold EXEL?
          The average age of EXEL Holders is between 35–55.
            What other stocks have EXEL investors also bought?
            EXEL Investors also bought MRK, SQ, TTD, MU, GE, NOW, CSCO, MELI, QCOM, CRM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              AAgilent
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis